08:30 AM - 08:45 AM

Neoadjuvant atezolizumab in resectable non-small cell lung cancer (NSCLC): Interim analysis and biomarker data from a multicenter study (LCMC3).

Location: Le Meridian AL Khobar, Saudi Arabia

Social Share

× How can I help you?